BIAF · bioAffinity Technologies, Inc. · Metrics
$1.76
-0.09 (-4.86%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current expected level of operating expenditures, current expected levels of revenue, and the cash and cash equivalents on hand at September 30, 2026, of $2.6 million, management concludes that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements contained in this Quarterly Report.”View the 10-Q filed Nov 6, 2026
Market Cap
$3.37M
Shares
1.82M
Volume · Nov 20
16.51K
Avg daily vol (63 sessions)
3.6M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
BIAF metrics
68 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$1.85
Market cap
$3.37M
Price action
23 metricsPrice change (1W)
-20.9%
Price change (30D)
-48.2%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$71.10
52-week low
$1.85
Change from 52-week high
-97.4%
Change from 52-week low
+0.0%
Annualized volatility
256.2%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
33.0
Price vs SMA 50
-60.1%
Price vs SMA 200
—
Avg volume (3M)
3.60M
Relative volume
0.0
Average dollar volume
$32.14M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
1.82M
Valuation
12 metricsP / E (TTM)
0.0
Trailing earnings · reciprocal yield 3,327.6%
PEG ratio
—
EV / revenue
0.2×
reciprocal yield 565.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 164.1%
P / book
0.9
reciprocal yield 116.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-457.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
38.4×
reciprocal yield 2.6%
EV / revenue historical average (5Y)
38.4×
reciprocal yield 2.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2023-05-15
Profitability
9 metricsGross margin
—
Operating margin
-246.1%
Trailing 12 months
Net margin
-278.9%
Gross profit (TTM)
$245,289
Operating profit (TTM)
−$13.60M
Net income (TTM)
−$15.41M
Trailing 12 months
Diluted EPS (TTM)
$61.56
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-26.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,160.8%
Year over year · more shares
Revenue CAGR (3Y)
-3.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-393.7%
Return on assets
-204.0%
Debt / equity
0.0
Current ratio
1.5
EBITDA (TTM)
−$13.23M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
-270.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$2.39M
Latest balance sheet
Cash & equivalents
$2.55M
Total assets
$7.55M
Total debt
$160,000
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$12.86M
Capital expenditures (TTM)
$172,684
R&D (TTM)
$1.47M
SG&A (TTM)
$11.90M
Stock compensation (TTM)
$1.00M
R&D / revenue
26.7%
Stock compensation / revenue
18.2%
Ownership (13F)
9 metrics13F filers
14
13F filer change QoQ
-7
Institutional ownership
16.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
28.0%
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+1,351.1%
Holder tenure
2.1
Price vs estimated holder cost
-78.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.4%
Short interest
3 metricsShort interest
2.9%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1712762
CUSIP
09076W406
13F (30d)
21 filings
14 filers
Visit website
Investor relations